Javier Orozco-Mera,Fernando Peralta-Pizza,Oscar Escobar-Vidarte et al.
Javier Orozco-Mera et al.
Background: Glioblastoma is the most common primary neoplasm of the central nervous system. Standard treatment includes surgery with maximum safe resection and radiotherapy plus concomitant and adjuvant chemotherapy; howe...
Ocular Toxicities of MEK Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysis [0.03%]
肉瘤患者使用MEK抑制剂引起的眼毒性：系统回顾和荟萃分析
Jing Han,Juejing Chen,Hanqiong Zhou et al.
Jing Han et al.
Background: Mitogen-activated protein kinase (MEK) inhibitors, which integrate the important signaling chain of the RAS-RAF-MEK-ERK1/2 pathway, regulate cell functions such as division and proliferation for patients with ...
Julia Dai,Madeleine Duvic
Julia Dai
Cutaneous T-cell lymphomas (CTCLs) are clinically heterogeneous T-cell lymphomas that arise in the skin and are characterized by their clinical and pathological features. This review will focus on mycosis fungoides (MF) and Sézary syndrome...
COVID-19 Vaccination in Patients With Cancer and Recipients of Cellular Therapy [0.03%]
癌症患者和接受细胞治疗患者的COVID-19疫苗接种
Fareed Khawaja,Marilyne Daher,Amy Spallone et al.
Fareed Khawaja et al.
COVID-19 continues to disproportionately affect patients with cancer because of their underlying immunocompromised state. Strategies to mitigate the impact of COVID-19 on patients with cancer include vaccination, which has demonstrated some...
Survival of Patients With Inoperable Non-Small Cell Lung Cancer With Baseline Severe Pulmonary Dysfunction: Impacts of Thoracic Radiotherapy and Predictive Analysis for Acute Radiation Pneumonitis [0.03%]
基线肺功能严重下降的不可手术非小细胞肺癌患者的生存情况：胸部放疗的影响及放射性肺炎预测分析
Qianyue Deng,Yingjie Zhang,Yanying Li et al.
Qianyue Deng et al.
Background and purpose: Currently, there is no standard treatment for patients with lung cancer with deteriorated pulmonary function. In this study, we aimed to assess the efficacy of thoracic radiotherapy for unresectabl...
Shorter Time to Treatment Is Associated With Improved Survival in Rural Patients With Breast Cancer Despite Other Adverse Socioeconomic Factors [0.03%]
农村乳腺癌患者接受治疗时间较短与生存改善相关，尽管存在其他不利的社会经济因素
Minh-Tri Nguyen,Wei Wei,Gregory Cooper et al.
Minh-Tri Nguyen et al.
Background: Cancer care in rural areas poses unique challenges, including access and proximity to care. This study examined differences in time to treatment initiation (TTI), a potential surrogate for access, and predicto...
Effectiveness, Toxicity, and Survival Predictors of Regorafenib in Metastatic Colorectal Cancer: A Multicenter Study of Routinely Collected Data [0.03%]
瑞戈非尼在转移性结直肠癌中的有效性，毒性和生存预测因子：常规收集数据的多中心研究
Alberto Calvo-García,María Pérez Abánades,Silvia Ruíz-García et al.
Alberto Calvo-García et al.
Objectives: To assess the effectiveness and toxicity of regorafenib in patients with metastatic colorectal cancer (mCRC) in routine clinical practice, as well as predictive factors of effectiveness. ...
Multicenter Study
Oncology (Williston Park, N.Y.). 2022 Dec 20;36(12):732-738. DOI:10.46883/2022.25920981 2022
The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory Disease [0.03%]
DLBCL中放射治疗作用的演变：从早期疾病到难治性疾病
Gavin Jones,John P Plastaras,Andrea K Ng et al.
Gavin Jones et al.
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma. Historically, radiation therapy (RT) served as the primary treatment modality for patients with localized disease. While still an option for select pa...
Irina Melnichenko,Lilit Sargsyan,Karen Bedirian et al.
Irina Melnichenko et al.
Yancey Warren,Anna Hecksher,Courtney Schepel et al.
Yancey Warren et al.
Small studies have demonstrated the benefit of integrative oncology (IO) therapies in patients with breast cancer; however, referral patterns and timing of therapies are unknown. This study describes the referral pattern and utilization of ...